Everyone has heard of CBD and today, with all the media hype and marketing, it is hard not to have heard something about it. Even your Grandparents will have heard positive things about CBD, but what are the authorities saying?
After over a century of irresponsible treatment of our environment, our plant -humanity is in need of a quick solution. Hemp may just be one of the pieces to this giant puzzle.
Within the last decade, cannabidiol (CBD) has become one of the most popular natural alternative medicines for people around the world. With such a versatile amount of health bene¬ts, CBD seems to provide a therapeutic solution for almost anyone out there.Due to this, more and more people seek to give CBD a try.
I am talking about Sweet Pure Auto CBD® (SWS75), a 6th generation autoflowering strain included in the Sweet Seeds® therapeutic line due to its high CBD content and which has been shown a very good acceptance after its release in the market. In addition to its high cannabidiol (CBD) content, another highly valued feature is that it contains almost no THC (less than 1%), so it has no psychoactive effects.
Cannabinoid compounds include phytocannabinoids, endocannabinoids, and synthetics. The two primary phytocannabinoids are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), with CB1 receptors in the brain and peripheral tissue and CB2 receptors in the immune and hematopoietic systems.
Purpose: New regulations are in place at the federal and provincial levels in Canada regarding the way medical cannabis is to be controlled. We present them together with guidance for the safe use of medical cannabis and recent clinical trials on cannabis and pain.
Back in 1990, scientists made a remarkable discovery that both changed the way we view the human body and cannabis: the endocannabinoid system.
The most productive autoflowering varieties of Buddha Seeds you’ll want to grow
The Dinafem breeders came across this plant in North California, it instantly fascinated the Spaniards with its extraordinary citrus/choco aroma.
Insufficient management of cancer-associated chronic and neuropathic pain adversely affects patient quality of life. Patients who do not respond well to opioid analgesics, or have severe side effects from the use of traditional analgesics are in need of alternative therapeutic op-tions.